Suburban Research Associates is seeking participants between 18 to 70 years old who have a diagnosis of depression for a research study. The study is about 12 months long and may include up to 11 visits to the office. Compensation will be provided if you are deemed eligible to participate.
Major Depressive Disorder in adults can be incredibly challenging to manage, as it often manifests in persistent feelings of sadness, hopelessness, and a loss of interest in activities once enjoyed. Finding effective treatments can prove difficult, as individuals may respond differently to various therapies and medications.
The purpose of this study is to test an investigational medication and see if it can help regulate mood in people who are struggling with this Major Depressive Disorder. The active ingredient in ALTO-300, the investigational medication, is already approved in Europe and Australia, but it is not approved by the U.S. FDA. Since all antidepressants work differently in people, it is important to test new medications to gain a better understanding of which patients may respond to certain treatments.
*Please note, other qualifications apply
Please fill out the form below if you would like to register your interest for an upcoming Type 1 Diabetes
To find out if you might be eligible for an upcoming chronic cough study, please fill out the form below.
Suburban Research Associates is conducting a research study evaluating an investigational medication in individuals living with bipolar I or II
Suburban Research Associates is conducting a research study to evaluate an investigational medicine for individuals who experience migraines.
Suburban Research Associates is seeking participants between 18-65 years old for a social anxiety research study. This study will last
Suburban Research Associates is seeking participants between 18 to 70 years old who have a diagnosis of depression for a
© 2024 Suburban Research Associates
